The GH Research Society will be holding its 16th Workshop on the topic of Safety of GH Treatment in Cancer and Intracranial Tumor Survivors in Children and Adults.
This invitation-only workshop will be performed through a web-based platform. We have adapted the schedule of this web-based structure with short online meetings taking place on three different occasions this year (June 9th and 16th, and September 29th). The workshop is organized with the support of the European Society of Endocrinology. Other major endocrine societies have also been invited to nominate delegates to the workshop.
Additionally, representatives from the regulatory agencies, EMA and FDA, will attend. A review paper on the topic has been written by members of the program organizing committee, and it will be distributed to the delegates prior to the start of the meeting. The format of each workshop has been modified over the years, but the backbone of plenary lectures will set the scene followed by breakout group discussions of more specific themes or questions.
The final session will be devoted to drafting a statement summarizing the outcome of the workshop that will be submitted for publication. GRS has published the results of its previous 15 workshops that have ‘stood the test of time’.